Category: Oncology/Hematology
Oncology/Hematology market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Non-Small Cell Lung Cancers
The 2025-2030 World Outlook for Non-Small Cell Lung Cancers This study covers the world outlook for non-small cell lung cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Non-Melanoma Skin Cancers
The 2025-2030 World Outlook for Non-Melanoma Skin Cancers This study covers the world outlook for non-melanoma skin cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Noninvasive Cancer Diagnostics
The 2025-2030 World Outlook for Noninvasive Cancer Diagnostics This study covers the world outlook for noninvasive cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Veterinary Oncology
The 2025-2030 World Outlook for Veterinary Oncology This study covers the world outlook for veterinary oncology across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Cancer Immunotherapies
The 2025-2030 World Outlook for Cancer Immunotherapies This study covers the world outlook for cancer immunotherapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Pap Smear Tests for Cervical Cancer Diagnostic Testing
The 2025-2030 World Outlook for Pap Smear Tests for Cervical Cancer Diagnostic Testing This study covers the world outlook for pap smear tests for cervical cancer diagnostic testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More
-
The 2025-2030 World Outlook for Kidney Cancer-Treating Drugs
The 2025-2030 World Outlook for Kidney Cancer-Treating Drugs This study covers the world outlook for kidney cancer-treating drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Lymphoma Treatments
The 2025-2030 World Outlook for Lymphoma Treatments This study covers the world outlook for lymphoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Malignant Melanoma Treatments
The 2025-2030 World Outlook for Malignant Melanoma Treatments This study covers the world outlook for malignant melanoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments
The 2025-2030 World Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments This study covers the world outlook for bile duct cancer (cholangiocarcinoma) treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ... Read More
-
The 2025-2030 World Outlook for Alkylating Gynaecological Cancer Drugs
The 2025-2030 World Outlook for Alkylating Gynaecological Cancer Drugs This study covers the world outlook for alkylating gynaecological cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2025-2030 World Outlook for Urothelial Cancer Drugs
The 2025-2030 World Outlook for Urothelial Cancer Drugs This study covers the world outlook for urothelial cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Endometrial Cancer Treatments
The 2025-2030 World Outlook for Endometrial Cancer Treatments This study covers the world outlook for endometrial cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Embolization in Interventional Oncology
The 2025-2030 World Outlook for Embolization in Interventional Oncology This study covers the world outlook for embolization in interventional oncology across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for Cancer Cachexia
The 2025-2030 World Outlook for Cancer Cachexia This study covers the world outlook for cancer cachexia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2025-2030 World Outlook for Cancer Immunotherapy Monoclonal Antibodies
The 2025-2030 World Outlook for Cancer Immunotherapy Monoclonal Antibodies This study covers the world outlook for cancer immunotherapy monoclonal antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2025-2030 World Outlook for Head and Neck Cancers
The 2025-2030 World Outlook for Head and Neck Cancers This study covers the world outlook for head and neck cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Cancer Diagnostics
The 2025-2030 World Outlook for Cancer Diagnostics This study covers the world outlook for cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Cancer Supportive Care Drugs
The 2025-2030 World Outlook for Cancer Supportive Care Drugs This study covers the world outlook for cancer supportive care drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Interventional Oncology
The 2025-2030 World Outlook for Interventional Oncology This study covers the world outlook for interventional oncology across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Interventional Oncology Devices
The 2025-2030 World Outlook for Interventional Oncology Devices This study covers the world outlook for interventional oncology devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Cervical Cancer Treatments
The 2025-2030 World Outlook for Cervical Cancer Treatments This study covers the world outlook for cervical cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Transitional Cell Bladder Cancer Therapeutics
The 2025-2030 World Outlook for Transitional Cell Bladder Cancer Therapeutics This study covers the world outlook for transitional cell bladder cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
-
The 2025-2030 World Outlook for In Vitro Colorectal Cancer Testing
The 2025-2030 World Outlook for In Vitro Colorectal Cancer Testing This study covers the world outlook for in vitro colorectal cancer testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancer Treatments
The 2025-2030 World Outlook for Colorectal Cancer Treatments This study covers the world outlook for colorectal cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
Research Assistance
